Clinical experiences with vecuronium in children

Area of Science:

• Anesthesiology
• Pediatric Pharmacology

Background:

• Neuromuscular blocking agents are crucial in pediatric anesthesia.
• Vecuronium is a non-depolarizing neuromuscular blocker with established use.

Purpose of the Study:

• To evaluate the efficacy and safety of vecuronium for endotracheal intubation in children.
• To determine the optimal dose for pediatric anesthesia.

Main Methods:

• A clinical study involving 40 pediatric patients.
• Administration of vecuronium at two doses: 0.08 mg/kg and 0.1 mg/kg body weight.
• Single intravenous bolus injection for endotracheal intubation.

Main Results:

• The 0.1 mg/kg dose of vecuronium ensured satisfactory clinical relaxation for ideal intubation in all patients.
• Key benefits included ease of intubation, intermediate duration of action, and smooth reversal.
• Cardiovascular stability and absence of serious adverse events were observed.

Conclusions:

• Vecuronium, at a dose of 0.1 mg/kg, is a useful and safe muscle relaxant in pediatric anesthesia.
• It facilitates effective endotracheal intubation with a favorable safety profile.